Schering-Plough Products, LLC | Merck | environmental violation | 2011 | EPA | $260,000 |
Roche Molecular Systems, Inc. | Roche | environmental violation | 2011 | EPA | $90,000 |
MERCK & CO., INC. | Merck | environmental violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
ELI LILLY AND COMPANY | Eli Lilly | environmental violation | 2011 | EPA | $337,500 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | environmental violation | 2011 | EPA | $135,756 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2011 | EPA | $900,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
Abbott Laboratories Inc. | AbbVie | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | environmental violation | 2012 | EPA | $68,475 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
Sanofi-Aventis U.S. Inc. | Sanofi | False Claims Act and related | 2012 | DOJ_CIVIL | $109,000,000 |
Pfizer H.C.P. Corporation | Pfizer | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
Eli Lilly and Company | Eli Lilly | Foreign Corrupt Practices Act | 2012 | SEC | $29,398,734 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Phibrochem, Inc. | Phibro Animal Health | export control violation | 2012 | BIS | $31,000 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Dava Pharmaceuticals Inc. | Endo International | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
BIOVAIL AMERICAS CORP. | Bausch Health | benefit plan administrator violation | 2012 | EBSA | $10,001 |
Parexel International, LLC | Parexel International | labor relations violation | 2012 | NLRB | $253,000 |
Novartis | Novartis | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
Genentech | Roche | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
Hoffmann-La Roche, Inc. | Roche | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
Schering-Plough Corporation | Merck | benefit plan administrator violation | 2012 | private lawsuit-federal | $12,250,000 |
Merck & Co., Inc. | Merck | benefit plan administrator violation | 2012 | private lawsuit-federal | $10,400,000 |
Abbott Laboratories | AbbVie | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643 |
Actavis | AbbVie | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Forest Laboratories, Inc. | AbbVie | False Claims Act and related | 2012 | ID-AG | $790,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2012 | TX-AG | $158,000,000 |
Merck Sharp & Dohme Corp. | Merck | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | False Claims Act and related | 2012 | ID-AG | $625,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $42,900,000 |
Pfizer, Inc. | Pfizer | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
Sanofi-Aventis U.S. LLC | Sanofi | False Claims Act and related | 2012 | ID-AG | $828,500 |
Schering-Plough | Merck | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
Advanced Sterilization Products | Johnson & Johnson | environmental violation | 2012 | CA-DPR | $25,616 |
Pfizer Inc. | Pfizer | environmental violation | 2012 | CA-DPR | $6,720 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
Abraxis Bioscience, Inc. | Bristol-Myers Squibb | environmental violation | 2012 | CA-SCAQMD | $5,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $37,500,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
Merck & Co. | Merck | consumer protection violation | 2012 | private lawsuit-state | $39,000,000 |
Omeros Corporation | Omeros Corp. | False Claims Act and related | 2012 | private lawsuit-federal | $3,940,000 |
PFIZER, INC. | Pfizer | workplace safety or health violation | 2012 | OSHA | $9,600 |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | workplace safety or health violation | 2012 | OSHA | $10,115 |
ALEXION PHARMACEUTICALS, INC. | AstraZeneca | workplace safety or health violation | 2012 | OSHA | $8,213 |
MERCK SHARP & DOHME CORPORATION | Merck | environmental violation | 2012 | EPA | $69,274 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
King Pharmaceuticals LLC | Pfizer | environmental violation | 2013 | EPA | $2,200,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | $2,250,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
EMD Millipore Corporation | Merck KGaA (EMD) | environmental violation | 2013 | EPA | $2,681,500 |
Ranbaxy USA Inc. | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2013 | DOJ_CIVIL | $5,475,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2013 | DOJ_CIVIL | $24,900,000 |
Novartis Pharmaceuticals | Novartis | employment discrimination | 2013 | OFCCP | $51,594 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | USAO | $3,500,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
Actavis Kadian, LLC | AbbVie | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $116,703 |
Intermune, Inc. | Roche | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $5,641 |
Intermune, Inc. | Roche | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $16,215 |
SIGMA-ALDRICH INC | Merck KGaA (EMD) | aviation safety violation | 2013 | FAA | $8,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | aviation safety violation | 2013 | FAA | $11,000 |
Wyeth | Pfizer | benefit plan administrator violation | 2013 | private lawsuit-federal | $2,000,000 |
Abbott Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
Abbott Laboratories, Inc. | Abbott Laboratories | consumer protection violation | 2013 | NY-AG | $25,000 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2013 | ID-AG | $1,000,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
Apotex | Apotex Corp. | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Astellas | Astellas Pharma | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
AstraZeneca | AstraZeneca | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |